NPHP3 p.Ser1252Arg
c.3756C>G · rs143451766 · VCV195996
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8228 | likely pathogenic |
|---|---|---|
| REVEL | 0.605 | indeterminate |
| SaProt | LLR -9.23 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4 | GERP -0.7, phastCons 1 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 11 kb · p 0.0019 · regional, not allelic |
| Overall | ||
| CADD | 23.7 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.114% | 874 |
| Middle Eastern | 0.066% | 1,515 |
| South Asian | 0.0593% | 1,686 |
| Remaining individualsnot grpmax-eligible | 0.0432% | 2,315 |
| Admixed American | 0.0233% | 4,286 |
| African / African-American | 0.0187% | 5,356 |
| Finnishnot grpmax-eligible | 0.0125% | 7,999 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NPHP3
- Protein
- p.Ser1252Arg
- Coding
- c.3756C>G
- MANE Select
- NM_153240
- dbSNP
- rs143451766
- Type
- single nucleotide variant
- Location
- chr3:132682759 (GRCh38)
- Gene constraint
- LOEUF 0.873 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 73.59 · 1 PDB
- Residue 1252
- a UniProt-annotated variant site (in nphp3)
Disease context
nephronophthisis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: renal-hepatic-pancreatic dysplasia 1NPHP3-related Meckel-like syndromenephronophthisis 3
For Nephronophthisis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Finland)
Similar variants
- NPHP3 c.1985+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP3 c.3201+1G>T Likely pathogenic ★★ same condition
- NPHP3 c.393+1G>C Likely pathogenic ★★ same condition
- NPHP3 c.520-1G>T Pathogenic ★★ same condition
- NPHP3 c.823+1G>T Likely pathogenic ★★ same condition
- NPHP3 c.958-2A>G Pathogenic ★★ same condition
- NPHP3 p.Arg1125Ter Pathogenic ★★ same condition
- NPHP3 p.Arg1259Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp3-p-ser1252arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown